As a full agonist at the two the CB1 and CB2 cannabinoid receptors, this chemical compound is classed as an analgesic medication. The analgesic results of cannabinoid ligands, mediated by CB1 receptors are well proven in procedure of neuropathic pain, and also cancer agony and arthritis.This product or service is usually a DEA exempt preparation o